scispace - formally typeset
T

Tetsuya Oshikawa

Researcher at University of Tokushima

Publications -  28
Citations -  836

Tetsuya Oshikawa is an academic researcher from University of Tokushima. The author has contributed to research in topics: Cytokine & Interleukin. The author has an hindex of 17, co-authored 28 publications receiving 804 citations. Previous affiliations of Tetsuya Oshikawa include National University of Colombia & University of North Carolina at Chapel Hill.

Papers
More filters
Journal ArticleDOI

Expression of Toll-Like Receptor 4 on Dendritic Cells Is Significant for Anticancer Effect of Dendritic Cell-Based Immunotherapy in Combination with an Active Component of OK-432, a Streptococcal Preparation

TL;DR: It is suggested that OK-PSA may be a potent adjuvant for local DC therapy, and that DC therapy followed by OK- PSA is able to elicit anticancer activity even in aTLR4-deficient host when TLR4 is expressed only in DCs injected intratumorally.
Journal ArticleDOI

Mechanism of anticancer host response induced by OK-432, a streptococcal preparation, mediated by phagocytosis and Toll-like receptor 4 signaling.

TL;DR: In in vivo experiments, the anticancer effect of OK-432 was significantly inhibited by suppression of phagocytosis activity by cytochalasin B, and in vitro experiments elucidated the mechanism mediated by phagocytes and TLR4 signaling in the immune effect ofOK-432.
Journal ArticleDOI

Mechanism for bone invasion of oral cancer cells mediated by interleukin‐6 in vitro and in vivo

TL;DR: Although interleukin (IL)‐6 accelerates osteoclastic bone resorption, it remains unclear whether IL‐6 may be involved in bone invasion of oral cancer.